Ice Cream Recall As FDA Sets Risk Level

The Food and Drug Administration (FDA) has recently classified the Zarlengo gelato recall as a Class II recall due to the presence of undeclared soy allergens in over 2,200 products sold in three states. This recall has raised concerns among consumers and has prompted the FDA to take swift action to ensure the safety of the public. The recall was initiated by Zarlengo Italian Ice & Gelato Company, a popular gelato manufacturer based in Denver, Colorado. The company voluntarily recalled their products after it was discovered that they contained soy, a known allergen, which was not declared on the label. This poses a serious health risk to individuals who are allergic to soy and could potentially lead to severe allergic reactions. The affected products were distributed to retail stores and restaurants in Colorado, Nebraska, and Wyoming. The recall includes various flavors of gelato, sorbetto, and ice cream, all of which were produced between January 1, 2019 and December 31, 2020. The products were sold in various sizes, including pints, quarts, and half-gallons, under the Zarlengo brand as well as private labels. The FDA has classified this recall as a Class II recall, which means that the products may cause temporary or medically reversible adverse health consequences. This classification is based on the severity of the potential health hazard and the likelihood of serious health consequences. The FDA has advised consumers who have purchased these products to immediately stop consuming them and return them to the place of purchase for a full refund. The FDA is also working closely with Zarlengo Italian Ice & Gelato Company to ensure that all affected products are removed from the market. The company has also taken necessary steps to address the issue and prevent it from happening in the future. They have implemented new labeling procedures and are conducting thorough inspections to ensure that all their products are safe for consumption. This recall serves as a reminder of the importance of proper labeling and the potential risks associated with undeclared allergens. The FDA has strict regulations in place to ensure that food manufacturers accurately label their products to protect consumers, especially those with food allergies. It is the responsibility of food manufacturers to ensure that their products are safe for consumption and properly labeled. The FDA is also urging consumers to be vigilant and check the labels of food products, especially if they have food allergies. It is important to always read the ingredient list and allergen information before consuming any food product. If you have any concerns or questions, do not hesitate to contact the manufacturer or the FDA for more information. The FDA is committed to protecting the public's health and will continue to monitor the situation closely. They are also working with Zarlengo Italian Ice & Gelato Company to ensure that all affected products are removed from the market and that proper measures are taken to prevent similar incidents in the future. In conclusion, the FDA's classification of the Zarlengo gelato recall as a Class II recall highlights the importance of proper labeling and the potential risks associated with undeclared allergens. The FDA is taking necessary steps to ensure the safety of the public and is working closely with the manufacturer to address the issue. It is crucial for consumers to be aware of food allergies and always check the labels of food products before consuming them. Let us all work together to ensure the safety of our food supply and protect the health of our communities.